Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 2:35 PM ET

Healthcare Equipment and Supplies

Company Overview of Imthera Medical, Inc.

Company Overview

Imthera Medical, Inc. develops implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). It offers aura6000 system, which delivers the targeted hypoglossal neurostimulation sleep therapy through a multi-contact electrode array that targets stimulation to subsets of the hypoglossal nerve to increase muscle tone in key tongue muscles during sleep, thereby opening the upper airway and treating OSA; and automatically cycles stimulation between various tongue muscles to prevent fatiguing any single muscle. Imthera Medical, Inc. was founded in 2004 and is based in San Diego, California.

12555 High Bluff Drive

Suite 310

San Diego, CA 92130

United States

Founded in 2004





Key Executives for Imthera Medical, Inc.

Chief Executive Officer, President and Director
Age: 57
Chief Technology Officer and Vice President of Engineering
Account Director
Vice President of Business Development
Compensation as of Fiscal Year 2015.

Imthera Medical, Inc. Key Developments

ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device

ImThera Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study. The THN3 Study will evaluate the safety and effectiveness of the aura6000(R) System for moderate to severe obstructive sleep apnea (OSA) in individuals who are unable to comply or unwilling to try PAP therapy or other OSA treatments. Data from this pivotal clinical study will be used to support a Pre-Market Approval (PMA) application for the aura6000 System.

Similar Private Companies By Industry

Company Name Region
Next Safety, Inc. United States
LUMOS INC. United States
Archer OpTx, Inc. United States
Ultimate Medical Services, Inc. United States
Medical Technology Resources, LLC United States

Recent Private Companies Transactions

Private Placement
March 16, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Imthera Medical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at